Select the type of procedure
21062080
1
Enquiry period
with
22.08.2022 17:32
to 02.09.2022 10:00
to 02.09.2022 10:00
2
Bidding period
with
02.09.2022 10:00
to 23.09.2022 11:00
to 23.09.2022 11:00
3
Auction
will not be used
4
Evaluation
5
Contract
Status
Evaluation
Estimated value without VAT
16 646 632,16 MDL
Period of clarifications:
22 Aug 2022, 17:32 - 2 Sep 2022, 10:00
Submission of proposals:
2 Sep 2022, 10:00 - 23 Sep 2022, 11:00
Supplier technical support:
(+373) 79999801
This procedure is carried out without auction. Your offer is final and must contain the entire list of required documents.
Subscribe impossible
during the period Evaluation
“Achiziţionarea medicamentelor pentru realizarea Programului Naţional de prevenire și control HIV/SIDA și ITS pentru anul 2023”
Information about customer
Fiscal code/IDNO
Address
MD-2009, MOLDOVA, mun.Chişinău, locality, MD-2009, Republica Moldova, Chişinău str. Cosmescu 3
Web site
---
The contact person
Purchase data
Date created
22 Aug 2022, 17:14
Date modified
22 Aug 2022, 17:32
Achizitii.md ID
21062080
MTender ID
CPV
33600000-6 - Produse farmaceutice
Type of procedure
Open tender
Award criteria
The lowest price
Funding sources
List of lots
Lot nr. 3 - Benzathini benzylpenicillinum 2400000 UI
Budget: 484692.8 MDL
Purchase has not taken place
Lot nr. 10 - Emtricitabine+Tenofovir disoproxil sau Emtricitabine+Tenofovir disoproxil fumarat 200/245mg sau 200/300mg
Budget: 549116.35 MDL
Purchase has not taken place
Lot nr. 12 - Lamivudinum + Zidovudinum* 150 mg + 300 mg
Budget: 4450.2 MDL
Purchase has not taken place
Lot nr. 13 - Lamivudinum + Zidovudinum* 30 mg + 60 mg
Budget: 20482.46 MDL
Purchase has not taken place
Lot nr. 18 - Sulfamethoxazolum+Trimethoprimum 200 mg+40 mg/5 ml 80 ml
Budget: 10156.8 MDL
Active
Lot nr. 20 - Tenofoviri alafenamide + Emtricitabinum 25 mg + 200 mg
Budget: 717469.58 MDL
Active
Lot nr. 21 - Tenofoviri disoproxili fumaras+Lamivudinum+Dolutegravirum 300mg+300mg+50mg
Budget: 9105621.71 MDL
Active
Documents of the procurement procedure
Only authorized platform users may ask questions during the clarification period.
Document successfully signed
OK